When Eric was diagnosed with HIV at the age of 26, a doctor delivered a prognosis that might have ended the conversation for many patients. He was told to prepare for his own funeral and to abandon the hope of ever having children. Years later, that same diagnosis has become the foundation of a personal […]
From Devastating Diagnosis to HIV Activism: Eric’s Story From Burundi Read More »
Health authorities in the Democratic Republic of the Congo have launched a clinical trial aimed at evaluating treatments for Ebola, as the country continues to grapple with an outbreak of the deadly haemorrhagic fever. The initiative comes amid mounting concern over the scale of the crisis and the limited therapeutic options currently available to frontline
Clinical trial of Ebola treatments begins in DR Congo as outbreak continues Read More »
In a historic move that could transform child health outcomes across Africa, the World Health Organization (WHO) has prequalified the first-ever malaria treatment specifically formulated for newborns and young infants. The treatment—a pediatric formulation of artemether-lumefantrine, marketed as Coartem Baby—received WHO prequalification on April 24, 2026, just ahead of World Malaria Day on April 25.
WHO Approves First-Ever Malaria Treatment for Newborns: A Game-Changer for Africa Read More »
While the world’s attention remains fixed on emerging infectious disease threats, a quieter — and in many ways deadlier — crisis has taken root across the African continent. Antimicrobial resistance (AMR), the process by which bacteria, viruses, fungi, and parasites evolve to defeat the drugs designed to kill them, is now responsible for more deaths
Nigeria’s resident doctors are on indefinite strike over unpaid salaries and systemic underfunding. With hospitals shuttered and patients dying in corridors, the healthcare crisis has reached breaking point.
When Senegal’s parliament approved one of Africa’s most punitive anti-LGBT laws in March 2026, advocates for people living with HIV feared the worst. Their concerns are now being confirmed. New data suggests that access to testing, treatment, and prevention services for vulnerable populations has collapsed, threatening to unravel one of sub-Saharan Africa’s most celebrated HIV
Revolutionary CRISPR-based sickle cell therapies are raising unprecedented hope across Africa — the continent that carries 85 percent of the global disease burden — even as the $2.2 million price tag places cures forever out of reach for most patients.
